/
/
/

Ganga Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Mar 2018Sep 2017Mar 2017Sep 2016Mar 2016
₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹2 Cr
₹7 L₹7 L₹72 L₹7 L₹0
₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr
₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr
₹29 L₹18 L₹22 L₹24 L₹19 L
₹14 L₹14 L₹16 L₹16 L₹17 L
₹11 L₹1 L₹7 L₹4 L₹70,000
₹9 L₹1 L₹5 L₹2 L₹20,000

Share Price Live Stats

Open (₹)0.00
Volume (₹)0.00
High (₹)0.00
Upper Circuit15.00
Low (₹)0.00
Lower Circuit10.00
Prev Close12.50
52W High (₹)13.97
Price12.50
52W Low (₹)9.35

Share Market Cap & Key Ratios Overview

M.Cap (₹)7.39 Cr
Div. Yield (%)0.00
PE Ratio73.16
Debt to Equity0.22
Price to Book0.76
Book Value13.46
EPS (TTM)0.17
Face Value10.00
ROE (%)1.22

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
GANGAPHARM-MNSE
LTP
1W Low
1W High
Market cap (₹)
1853+17.5 (0.95%)
1835.50
1890.40
4,47,476Cr
9613+246 (2.63%)
9305.95
9739.85
2,54,764Cr
4935+130.75 (2.72%)
4864.80
5010
1,89,423Cr
1180+27 (2.34%)
1152
1191
1,16,658Cr
1404+32.55 (2.37%)
1364
1418.70
1,11,484Cr
2026.25+71 (3.63%)
1964.50
2054.55
1,09,943Cr
2475+157 (6.77%)
2302.30
2503.20
1,01,712Cr
1200.4+29.3 (2.50%)
1186.20
1221.60
1,01,005Cr
1720-15 (-0.86%)
1690
1739.60
99,253Cr
2098-46.7 (-2.18%)
2084.50
2129.85
96,031Cr
12.5+0 (0.00%)
12.50
12.50
7Cr

Key Highlights of Ganga Pharmaceuticals Ltd’s P&L

In 2025-03-31, Ganga Pharmaceuticals Ltd reported total revenue of ₹2.64Cr, compared with ₹2.74Cr in 2024-03-31, reflecting Ganga Pharmaceuticals Ltd turnover.

Depreciation was ₹4.65Lakh and finance costs were ₹17.85Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹9.47Lakh in 2025-03-31 as compared to ₹6.33Lakh in 2024-03-31.

Net Profit (PAT) was ₹7.9Lakh in 2025-03-31 compared with ₹4.66Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.16 in 2025-03-31, compared with ₹0.10 in 2024-03-31.